CD44 and breast carcinoma: Here, we report the isolation of subsets of EpCAM-negative breast cancer CTCs containing stem-cell properties (CD44+/CD24−) by multiparametric flow cytometry with a combinatorial uPAR and int β1 expression and their abilities to grow long-term in vitro.